Effect of Nutritional Support on Clinical Outcomes of Intensive Care Unit Patients
Pengaruh Nutritional Support terhadap Luaran Klinis pada Pasien Intensive Care Unit
Downloads
Background: Nutritional support is a globally acknowledged standard of care for critically ill patients, forming an integral component of clinical therapy in Intensive Care Units (ICUs) to enhance overall clinical outcomes.
Objectives: This study aimed to assess the impact of enteral nutritional support on clinical outcomes in ICU patients.
Methods: This research adopted a systematic review approach, focusing on Randomized Controlled Trial (RCT) studies conducted between 2010 and 2020. The review adhered to the PRISMA guidelines. The clinical outcomes studied included length of stay in the hospital, length of stay in the ICU, and mortality.
Discussion: Among 897 reviewed articles, only 6 articles were relevant. The study respondents were ICU in patients who received enteral formula, both in the control and intervention groups. The intervention group received an enteral formula featuring modified energy (normocaloric and high protein) and nutrients (enriched with pectin and immunse-modulating nutrients). Nutritional support in the form of enteral nutrition has varying effects on the length of hospitalization, ICU, and mortality.
Conclusions: No significant difference was observed in ICU and hospital stays between patients receiving standard enteral/hypocaloric/high protein nutrition and those receiving enteral nutrition enriched with pectin or immune-modulating nutrients. However, patients receiving enteral nutrition with immune-modulating nutrients experienced a reduced length of hospitalization. The administration of immune-modulating nutrients was associated with an increased risk of mortality at 60 and 28 days in critically ill patients.
Seron-Arbeloa. Enteral Nutrition in Critical Care. J Clin Med Res (2013) doi:10.4021/jocmr1210w.
Ridley, E., Gantner, D. & Pellegrino, V. Nutrition therapy in critically ill patients- a review of current evidence for clinicians. Clinical Nutrition vol. 34 565–571 Preprint at https://doi.org/10.1016/j.clnu.2014.12.008 (2015).
Vassilyadi F, P. A. P. C. Hallmarks in the history of enteral and parenteral nutrition: From antiquity to the 20th century. Nutrition in Clinical Practice 28, 209–217 (2013).
Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine vol. 6 Preprint at https://doi.org/10.1371/journal.pmed.1000100 (2009).
Mousavian, S. Z. et al. Randomized Controlled Trial of Comparative Hypocaloric vs Full-Energy Enteral Feeding During the First Week of Hospitalization in Neurosurgical Patients at the Intensive Care Unit. Journal of Parenteral and Enteral Nutrition 44, 1475–1483 (2020).
Pontes-Arruda, A. et al. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: Results from a multicenter, prospective, randomized, double-blinded, controlled study: The INTERSEPT Study. Crit Care 15, (2011).
Rugeles, S. et al. High-protein hypocaloric vs normocaloric enteral nutrition in critically ill patients: A randomized clinical trial. J Crit Care 35, 110–114 (2016).
Marik, P. E. & Hooper, M. H. Normocaloric versus hypocaloric feeding on the outcomes of ICU patients: a systematic review and meta-analysis. Intensive Care Medicine vol. 42 316–323 Preprint at https://doi.org/10.1007/s00134-015-4131-4 (2016).
Charles, E. J. et al. Hypocaloric compared with eucaloric nutritional support and its effect on infection rates in a surgical intensive care unit: A randomized controlled trial. American Journal of Clinical Nutrition 100, 1337–1343 (2014).
Arabi, Y. M. et al. Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults. New England Journal of Medicine 372, 2398–2408 (2015).
Van Zanten, A. R. H. et al. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: A randomized clinical trial. JAMA 312, 514–524 (2014).
Heyland, D. et al. A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients. New England Journal of Medicine 368, 1489–1497 (2013).
Needham, D. M. et al. One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: Prospective follow-up of EDEN randomised trial. BMJ (Online) 346, (2013).
Ibrahim, E. S. Enteral nutrition with omega-3 fatty acids in critically ill septic patients: A randomized double-blinded study. Saudi J Anaesth 12, 536–539 (2018).
Lu, C. et al. Omega-3 supplementation in patients with sepsis: a systematic review and meta-analysis of randomized trials. Ann Intensive Care 7, (2017).
Langlois, P. L., D’Aragon, F., Hardy, G. & Manzanares, W. Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Nutrition vol. 61 84–92 Preprint at https://doi.org/10.1016/j.nut.2018.10.026 (2019).
Chen, H. et al. Correlation analysis of omega-3 fatty acids and mortality of sepsis and sepsis-induced ARDS in adults: Data from previous randomized controlled trials. Nutrition Journal vol. 17 Preprint at https://doi.org/10.1186/s12937-018-0356-8 (2018).
Copyright (c) 2024 Amerta Nutrition
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
AMERTA NUTR by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under “the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
